CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 109 filers reported holding CYTEK BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $271 | -34.9% | 49,179 | +0.8% | 0.00% | – |
| Q2 2023 | $416 | -21.7% | 48,768 | -15.6% | 0.00% | – |
| Q1 2023 | $531 | +69.6% | 57,789 | +88.5% | 0.00% | – |
| Q4 2022 | $313 | -99.6% | 30,659 | +533.3% | 0.00% | – |
| Q3 2022 | $71,000 | -62.4% | 4,841 | -72.6% | 0.00% | – |
| Q2 2022 | $189,000 | -46.2% | 17,651 | -45.9% | 0.00% | – |
| Q1 2022 | $351,000 | – | 32,656 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,300,000 | $13,273,000 | 8.92% |
| Miura Global Management | 780,000 | $7,963,800 | 4.01% |
| RA Capital Management | 13,381,054 | $136,620,561 | 2.77% |
| HHLR ADVISORS, LTD. | 8,684,530 | $88,669,051 | 1.87% |
| Brown Capital Management | 5,107,878 | $52,151,434 | 0.86% |
| Perceptive Advisors | 1,289,534 | $13,166,142 | 0.37% |
| Hillsdale Investment Management Inc. | 344,529 | $3,517,641 | 0.30% |
| PURA VIDA INVESTMENTS, LLC | 420,749 | $4,295,847 | 0.22% |
| FOX RUN MANAGEMENT, L.L.C. | 19,881 | $202,985 | 0.08% |
| INNOVIS ASSET MANAGEMENT LLC | 14,565 | $148,709 | 0.07% |